A detailed history of Avion Wealth transactions in Repligen Corp stock. As of the latest transaction made, Avion Wealth holds 61 shares of RGEN stock, worth $8,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61
Previous 64 4.69%
Holding current value
$8,812
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$119.79 - $167.35 $359 - $502
-3 Reduced 4.69%
61 $9,000
Q2 2024

Jul 26, 2024

BUY
$120.0 - $182.95 $6,000 - $9,147
50 Added 357.14%
64 $8,000
Q4 2023

Jan 26, 2024

BUY
$114.17 - $185.35 $1,598 - $2,594
14 New
14 $3,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.